ARROWHEAD PHARMACEUTICALS, INC.

By person

14 insiders · 65 transactions

337×

Christopher Anzalone holds 337 times base salary in stock. $331.11M of shares against $981.05K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher Anzalone last reported holding, valued at $87.30, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Anzalone Christopher Richard

Chief Executive Officer

—

$24.01M (25)

−$24.01M

3,792,739

2.69%

$331.11M

+2.1%

Hamilton James C

Chief Medical Officer

—

$4.63M (10) scheduled

−$4.63M

226,958

0.1607%

$19.81M

+10.8%

O'Brien Patrick

COO

—

$3.12M (12) scheduled

−$3.12M

547,408

0.3875%

$47.79M

+17.9%

PERRY MICHAEL S

Director

—

$2.00M (2)

−$2.00M

111,459

0.0789%

$9.73M

−2.9%

Ferrari Mauro

Director

—

$1.02M (2) scheduled

−$1.02M

69,053

0.0489%

$6.03M

+13.6%

Apel Daniel Joseph

Chief Financial Officer

—

$934.29K (3) scheduled

−$934.29K

162,905

0.1153%

$14.22M

+61.3%

OLUKOTUN ADEOYE Y

Director

—

$850.54K (4) scheduled

−$850.54K

31,600

0.0224%

$2.76M

+38.3%

Vakiener Victoria

Director

—

$679.49K (3) scheduled

−$679.49K

35,723

0.0253%

$3.12M

+18.3%

Waddill William D.

Director

—

$566.04K (3) scheduled

−$566.04K

56,563

0.0400%

$4.94M

+18.2%

Lu Hongbo

Director

—

$228.33K (1) scheduled

−$228.33K

52,012

0.0368%

$4.54M

+70.9%

Myszkowski Kenneth Allen

Chief Financial Officer

—

455,433

0.3224%

$39.76M

+13.7%

GIVEN DOUGLAS B

Director

—

124,167

0.0879%

$10.84M

−4.3%

INGRAM DOUGLAS S

Director

—

46,215

0.0327%

$4.03M

—

Cohen Matthew Gregory

Director

—

11,882

0.0084%

$1.04M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

PERRY MICHAEL S

18 Aug 2026

Director

Sell

11,600

$87.30

$1.01M

OLUKOTUN ADEOYE Y

18 Aug 2026

Director

Sell

2,000

$86.96

$173.92K

Anzalone Christopher Richard

17 Dec 2025

Chief Executive Officer

Sell

1,981

$66.30

$131.34K

Anzalone Christopher Richard

17 Dec 2025

Chief Executive Officer

Sell

982

$65.53

$64.35K

Anzalone Christopher Richard

17 Dec 2025

Chief Executive Officer

Sell

35,750

$64.51

$2.31M

Anzalone Christopher Richard

17 Dec 2025

Chief Executive Officer

Sell

46,287

$63.55

$2.94M

Anzalone Christopher Richard

16 Dec 2025

Chief Executive Officer

Sell

3,221

$67.87

$218.61K

Anzalone Christopher Richard

16 Dec 2025

Chief Executive Officer

Sell

166

$66.77

$11.08K

Anzalone Christopher Richard

16 Dec 2025

Chief Executive Officer

Sell

1,300

$65.77

$85.50K

Anzalone Christopher Richard

16 Dec 2025

Chief Executive Officer

Sell

1,000

$64.96

$64.96K

Anzalone Christopher Richard

16 Dec 2025

Chief Executive Officer

Sell

6,661

$64.29

$428.24K

Anzalone Christopher Richard

16 Dec 2025

Chief Executive Officer

Sell

8,476

$62.94

$533.48K

Anzalone Christopher Richard

16 Dec 2025

Chief Executive Officer

Sell

14,095

$62.12

$875.58K

Anzalone Christopher Richard

16 Dec 2025

Chief Executive Officer

Sell

10,963

$61.25

$671.48K

Anzalone Christopher Richard

16 Dec 2025

Chief Executive Officer

Sell

8,416

$60.51

$509.25K

Anzalone Christopher Richard

15 Dec 2025

Chief Executive Officer

Sell

8,147

$69.96

$569.96K

Anzalone Christopher Richard

15 Dec 2025

Chief Executive Officer

Sell

21,321

$69.28

$1.48M

Anzalone Christopher Richard

15 Dec 2025

Chief Executive Officer

Sell

100,532

$68.67

$6.90M

PERRY MICHAEL S

5 Dec 2025

Director

Sell

16,250

$61.03

$991.74K

Ferrari Mauro

28 Nov 2025

Director

Sell

8,750

$56.39

$493.41K

Show all 65 transactions →

ARROWHEAD PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out